Past Updates
Spring-2008
We have added stability information for one new drug product: PANTOPRAZOLE. We are also reporting the results of compatibility studies for PANTOPRAZOLE in admixture with 90 parenteral products including: CASPOFUNGIN ACETATE, CIPROPLOXACIN, ENALAPRILAT, FLUCONAZOLE, LEVOFLOXACIN, MEROPENEM, PROPOFOL, VASOPRESSIN, and ZIDOVUDINE. Also included in the enclosed supplement is additional compatibility information for CEFTRIAXONE used with calcium-containing products.
Winter-2007
We have updated important new medication safety information on CEFTRIAXONE SODIUM, as reported by the U.S. Food and Drug Administration. We have added stability and compatibility information for one new drug product: CELLCEPT®. Also included is compatibility information for CASPOFUNGIN ACETATE, ALFENTANIL HYDROCHLORIDE, and CEFTAZIDIME in combination with numerous other parenteral drugs.
Fall-2007
We have added important new medication safety information on CEFTRIAXONE SODIUM, as reported by the U.S. Food and Drug Administration. We have also added stability and compatibility information for three new drug products: ARIPIPRAZOLE, CASPOFUNGIN ACETATE, and ROPIVACAINE HYDROCHLORIDE. Also included in this update are compatibility information for CEFEPIME, GANCICLOVIR, KETAMINE, KETOROLAC, and NESIRITIDE.
Summer-2007
We have added compatibility information for one new drug product: OXALIPLATIN. Included in this new drug monograph is compatibility information for over 50 different parenteral drug combinations, including: Bumetanide, Docetaxel, Dolasetron Mesylate, Enalaprilat, Gemcitabine Hydrochloride, Leucovorin Calcium, Ondansetron Hydrochloride, Paclitaxel, Ranitidine Hydrochloride, Topotecan Hydrochloride, and Verapamil Hydrochloride. The results of stability studies on PALONOSETRON HYDROCHLORIDE with CISPLATIN, CARBOPLATIN, METOCLOPRAMIDE HYDROCHLORIDE, and PROMETHAZINE HYDROCHLORIDE are also included in our 2007 Summer Supplement.
Spring-2007
We have added compatibility information for two new drug products: Piperacillin and Tazobactam , and Pemetrexed. Included in these two new drug monographs are compatibility information for over 80 different parenteral drug combinations, including: amifostine, amikacin, aztreonam, carboplatin, ciprofloxacin, dexrazoxane, docetaxel, doxorubicin, gentamicin, granisetron, irinotecan, ranitidine, topotecan, and zidovudine.
Winter-2006
We have added compatibility information for two new drugs: Nesiritide in combination with 30 different drugs, and infusion stability data for Insulin Aspart. In addition we have provided additional information for these existing drug monographs: Oxytocin, Palonosetron, Dacarbazine, Cefuroxime, and Leucovorin Calcium.
Fall-2006
We have added compatibility information for Lansoprazole in combination with seventy-eight different parenteral products including the following: Acyclovir, Gemcitabine, Alatrofloxacin, Gentamicin, Ceftriaxone, Labetalol, Cyclosporine, Midazolam, Droperidol, Morphine, Enalaprilat, Nicardipine, Etoposide, Paclitaxel, Famotidine, Ranitidine, Fentanyl, Vinorelbine, Ganciclovir, and Zidovudine.
Summer-2006
We have added compatibility information for a new drug, Lansoprazole. Also included are new data on the compatibility and stability of these drugs: Clonidine Hydrochloride, Fentanyl Citrate, Morphine Sulfate, Hydralazine Hydrochloride, and Vasopressin.
Spring-2006
We have added a new drug monograph, DEXMEDETOMIDINE HYDROCHLORIDE (PRECEDEX®), in this supplement. Over 90 different drugs were tested with this drug, including: Alfentanil, Amiodarone, Azithromycin, Aztreonam, Bretylium, Cefepime, Cimetidine, Dobutamine, Dolasetron, Enalaprilat, Esmolol, Famotidine, Gatifloxacin, Inamrinone, Ketorolac, Linezolid, Milrinone, Ofloxacin, Ondansetron, Propofol, Ranitidine, Sufentanil, Vancomycin, and Verapamil.
Winter-2005
We have added a new drug monograph, Tramadol Hydrochloride, in this supplement. Also included is new information for 46 different drugs including entries for these parenteral products: Argatroban, Cidofovir, Clonidine Hydrochloride, Dolasetron Mesylate, Doxorubicin Hydrochloride, Droperidol, Fentanyl Citrate, Gentamicin Sulfate, Ketamine Hydrochloride, Ketorolac Tromethamine, Levofloxacin, Lorazepam, Morphine Sulfate, Ondandestron Hydrochloride, Palonosetron Hydrochloride, Vancomycin Hydrochloride, and Zidovudine.
Fall-2005
Included in this supplement are new information for Bivalirudin, Fenoldopam Mesylate, and Teniposide in combination with dozens of other parenteral drug products. In addition, we have added monographs for Codeine Sulfate, Ammonium Chloride, and Amobarbital.
Summer-2005
Included in this Supplement are compatibility data for one new drug monograph, Drotrecogin Alfa, in combination with thirty-four different parenteral medications. Also included are compatibility data for Argatroban in combination with total parenteral nutrition solutions and with these drugs: Amiodarone hydrochloride, Furosemide, Fenoldopam Mesylate, Lidocaine Hydrochloride, Milrinone Lactate, Nitroglycerin, Nitroprusside Sodium, and Vasopressin.
Spring-2005
Included in this Supplement are compatibility data for two new drug monographs: Daptomycin and Palonosetron Hydrochloride. In addition we have added new information to these existing monographs: Co-Trimoxazole, Fluorouracil, Furosemide, Inamrinone Lactate, Levofloxacin, Nitroglycerin, Norepinephrine Bitartrate, Ondansetron Hydrochloride, and Potassium Phosphate.
Winter-2004
Included in this Supplement is new compatibility data for the following six drugs: DOXORUBICIN HYDROCHLORIDE, NITROPRUSSIDE, DOCETAXEL, HETASTARCH, TOTAL PARENTERAL NUTRITION SOLUTIONS, and BIVALIRUDIN. In addition, this update includes update pages to transfer two drugs to their current name: AMRINONE LACTATE is now INAMRINONE LACTATE and TRIMETHOPRIM SULFAMETHOXAZOLE is now CO-TRIMOXAZOLE.
Fall-2004
Included in this Supplement are compatibility data for five new drug monographs: Irinotecan Hydrochloride, Quinupristin and Dalfopristin, Reteplase, Streptokinase, and Anti-Thymocyte Globulin (Rabbit). In addition we have added new information to these existing monographs: Fenoldopam Mesylate, Bivalirudin, Enoxaparin Sodium, Phenylephrine Hydrochloride, and Eptifibatide.
Summer-2004
Included in this Supplement are compatibility data for four new drugs: Fenoldopam Mesylate (Corlopam®), Ertapenem (Invanz®), Epoprostenol Sodium (Flolan®), and Treprostinil Sodium (Remodulin®). In addition we have added new information to these existing monographs: Cefepime Hydrochloride, Cyclophosphamide, Dobutamine Hydrochloride, Mesna, Oxytocin, and Zidovudine.
Spring-2004
Included in this Supplement are compatibility data for Bivalirudin (Angiomax) with 96 other drugs.
Winter 2003
Included in this supplement are compatibility data for Vasopressin with these twelve different medications. Amiodarone, Lidocaine, Diltiazem, Milrinone, Dobutamine, Nitroglycerin, Dopamine, Norepinephrine, Epinephrine, Phenylephrine, Heparin, and Procainamide. In addition we have added the results of the physical compatibility of parenteral nutrition solutions with several several trace elements and other additives.
Fall 2003
Included in this Supplement are compatibility data for two new drug monographs, ARGATROBAN and DOXAPRAM. In addition, new information has been included for these existing monographs: Alcohol, Dacarbazine, Dexamethasone, Furosemide, Glycopyrrolate, Imipenem-Cilastatin, and Tenecteplase.
Spring 2003
Included in this Supplement are compatibility data for a new monograph for Hetastarch in Lactated Electrolyte Injection in combination with 100 other parenteral drugs. These data have also been added to the existing monographs for these 100 drugs.
Winter 2002
Included in this Supplement are compatibility data for these new drugs: Dihydroergotamine Mesylate, Tenecteplase, and Eptifibatide. In addition, new data have been added to the existing monographs for the following drugs: Abciximab, Alteplase, Amikacin, Amiodarone, Azithromycin, Aztreonam, Cefazolin, Cefotaxime, Ceftazidime, Ceftriaxone, Ciprofloxacin, Diltiazem, Diphenhydramine, Dobutamine, Dopamine, Dolasetron, Droperidol, Fentanyl, Furosemide, Gentamicin, Heparin, Imipenem-Cilastatin, Ketamine, Ketorolac, Labetalol, Levofloxacin, Lidocaine, Linezolid, Meperidine, Metoclopramide, Methylprednisolone, Metoprolol, Midazolam, Morphine, Nafcillin, Nitroglycerin, Ondansetron, Piperacillin-tazobactam, Potassium Chloride, Promethazine, Ticarcillin-Clavulanate, Tirofiban, Tobramycin, Total Parenteral Nutrition, Trimethoprim-Sulfamethoxazole, and Verapamil.
Fall 2002
The monograph for AMIODARONE has been expanded with the addition of admixture compatibility for 38 drugs. In addition, new data have been added to the existing monographs for the following drugs: Ampicillin Sodium, Baclofen, Bupivacaine Hydrochloride, Cisplatin, Clonidine Hydrochloride, Dexamethasone Sodium Phosphate, Doxorubicin Hydrochloride, Fentanyl Citrate, Lidocaine Hydrochloride, Mitomycin, Morphine Sulfate, Nafcillin Sodium, Oxacillin Sodium, Sufentanil Citrate, Verapamil Hydrochloride, Vincristine Sulfate.
Summer 2002
New drug monographs are included for : Abciximab, Alprostadil, and Morphine Hydrochloride. New data have been added to the existing monographs for over 60 drugs, including: Acyclovir, Cefotaxime, Ciprofloxacin, Dexamethasone, Docetaxel, Droperidol, Fentanyl, Foscarnet, Ganciclovir, Levofloxacin, Lidocaine, Lorazepam, Metoclopramide, Midazolam, Ranitidine, Tirofiban, Topotecan, and Vancomycin.
Spring 2002
With this supplement we have completed the updating of pH information that subscribers may use to help decide on the acid/base stability of parenteral admixtures. New pH stability information has been included for over 100 drug monographs.
Winter 2001
Included in our Winter 2001 supplement is a new monograph of compatibility information for CLARITHROMYCIN. Also included in the enclosed supplement are additional compatibility data to the existing monographs for: Carmustine Cefepime Hydrochloride Etoposide Phosphate Doxorubicin Hydrochloride Nitroprusside Sodium Tirofiban Hydrochloride Topotecan Hydrochloride Vincristine Sulfate In addition, and at the request of subscribers, we have provided updated information on pH for over 50 drug monographs.
Fall 2001
Included in the enclosed supplement are compatibility data for a new drug monograph, LINEZOLID. Research reports on linezolid in combination with over 100 different parenteral drugs comprise the entire Fall Supplement.
Summer 2001
Included in our Summer 2001 Supplement are new compatibility data in the monographs for these drugs: Acyclovir Sodium Alfentanil Hydrochloride Carboplatin Cefuroxime Cisplatin Cladribine Methylprednisolone Sodium Succinate Midazolam Hydrochloride Nafcillin Sodium Potassium Phosphate Sufentanil Total Parenteral Nutrition Solutions
Spring 2001
Included in our Spring 2001 Supplement, are data on one new drug: SUMATRIPTAN SUCCINATE. In addition new compatibility data for ALATROFLOXACIN, ALTEPLASE, AZTREONAM, CEFAZOLIN, CEFEPIME, CEFOXITIN, CEFTAZIDIME, CEFTRIAXONE, CEPHALOTHIN, CIPROFLOXACIN, GENTAMICIN, HEPARIN, KETAMINE, MORPHINE, RANITIDINE, AND VANCOMYCIN have been added to their respective drug monographs.
Winter 2000
Included in our Winter 2000 Supplement, are data on these new drugs: ALLOPURINOL SODIUM, DOLASETRON MESYLATE, DANAPAROID SODIUM, and VALPROATE SODIUM. In addition new compatibility data for BACLOFEN, BUPIVACAINE, CLONIDINE, DOBUTAMINE, FENTANYL,and TORSEMIDE have been added to their respective drug monographs. Fall 2000 Included in our Fall 2000 Supplement, are data on these new drugs: DALTEPARIN, OXYCODONE, and SOMATROPIN (rDNA). In addition new compatibility data for DOCETAXEL, ETOPOSIDE, GENTAMICIN, MEROPENEM, NALBUPHINE, NITROPRUSSIDE , and PROPAFENONE have been added to their respective drug monographs. Because of the change in the official name of AMRINONE to INAMRINONE, we have included compatibility information in the drug monographs under each name.